Bei Akademie registrieren
DrÀgerwerk, DE0005550636

DrÀgerwerk stock trades at EUR 100.40 as quarterly results near

Published on 10/25/2026 at 17:14 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS
DrÀgerwerk stock is EUR 100.40 in weekend trading on October 25, 2026 versus the Xetra close at EUR 100.60. Results are due October 29, 2026.

Upcoming results and market levels

  • On October 14, 2026, DrĂ€ger reported preliminary third-quarter EBIT of EUR 48 million.
  • DrĂ€gerwerk stock trades in weekend trading at Lang & Schwarz at EUR 100.40 at 5:12 p.m. CEST on October 25, 2026, 0.20 percent below the Xetra close of October 23, 2026.
  • DrĂ€ger plans to publish its third-quarter statement on October 29, 2026.
Bauhaus-Konstruktivismus-Poster mit MEDIZINTECHNIK-Schriftzug und geometrischen PrimÀrfarben
DrÀgerwerk AG & Co. KGaA Bauhaus-Poster Medizintechnik geometrische Formen PrimÀrfarben Konstruktivismus DE0005550636, Illustration mit AI erstellt.

DrÀgerwerk reported preliminary third-quarter EBIT of around EUR 48 million on October 14, 2026, down from EUR 56.7 million in the comparable quarter. Net sales rose to around EUR 851 million, while the company confirmed its 2026 forecast. The figures and outlook were published in an EQS News announcement.

At Lang & Schwarz, DrÀgerwerk stock trades in weekend trading at EUR 100.40 at 5:12 p.m. CEST on October 25, 2026. That is 0.20 percent below the Xetra close of October 23, 2026, at EUR 100.60. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of DrÀgerwerk stock.

The week in figures

The current weekend-trading price is EUR 100.40 against the Xetra close of October 23, 2026, at EUR 100.60. The comparison represents a decline of EUR 0.20, or 0.20 percent.

Chronology of the week

DrĂ€ger’s October 14 announcement said third-quarter net sales increased 1.0 percent on a currency-adjusted basis and 2.1 percent nominally. Order intake rose 7.0 percent on a currency-adjusted basis to around EUR 926 million. DrĂ€ger also continued to expect currency-adjusted 2026 net-sales growth of 2.0 percent to 6.0 percent and an EBIT margin of 6.0 percent to 8.0 percent. The announcement is available from EQS News.

Dates of the coming week

DrĂ€ger is scheduled to publish its quarterly statement for the third quarter of 2026 on October 29, 2026, at 7:30 a.m. CET, followed by a conference call. The date and schedule are listed on the company’s investor-relations calendar.

Market context: Market report DAX.

Disclaimer...
en | DE0005550636 | DRĂ€GERWERK | boerse | 70409810 | bgmi